Related Experiment Video
Updated: Nov 25, 2025

Analyzing DNA-Protein Interactions with Streptavidin-Based Biolayer Interferometry
Published on: January 17, 2025
APOBEC1 cytosine deaminase activity on single-stranded DNA is suppressed by replication protein A
Lai Wong1, Frederick S Vizeacoumar2, Franco J Vizeacoumar2,3
1Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan S7N 5E5, Canada.
Abstract:
Many APOBEC cytidine deaminase members are known to induce 'off-target' cytidine deaminations in 5'TC motifs in genomic DNA that contribute to cancer evolution. In this report, we characterized APOBEC1, which is a possible cancer related APOBEC since APOBEC1 mRNA is highly expressed in certain types of tumors, such as lung adenocarcinoma. We found a low level of APOBEC1-induced DNA damage, as measured by γH2AX foci, in genomic DNA of a lung cancer cell line that correlated to its inability to compete in vitro with replication protein A (RPA) for ssDNA. This suggests that RPA can act as a defense against off-target deamination for some APOBEC enzymes. Overall, the data support the model that the ability of an APOBEC to compete with RPA can better predict genomic damage than combined analysis of mRNA expression levels in tumors and analysis of mutation signatures.
Insights
APOBEC1, a cancer-related enzyme, causes minimal DNA damage in lung cancer cells. Its inability to bind single-stranded DNA (ssDNA) with replication protein A (RPA) suggests RPA protects against off-target deamination.
Area of Science:
- Biochemistry
- Genomics
- Cancer Biology
Background:
- APOBEC cytidine deaminases contribute to cancer evolution through off-target DNA deaminations.
- APOBEC1 is implicated in cancer, with high mRNA expression in lung adenocarcinoma.
Purpose of the Study:
- To characterize the DNA-damaging activity of APOBEC1.
- To investigate the role of replication protein A (RPA) in modulating APOBEC1 activity.
Main Methods:
- Assessed APOBEC1-induced DNA damage using γH2AX foci in a lung cancer cell line.
- Measured the in vitro competition between APOBEC1 and RPA for single-stranded DNA (ssDNA).
Main Results:
- APOBEC1 induced low levels of DNA damage in the tested lung cancer cell line.
- APOBEC1 showed limited ability to compete with RPA for ssDNA binding.
- RPA binding competition correlated with reduced APOBEC1-induced genomic damage.
Conclusions:
- RPA can act as a protective mechanism against off-target deamination by certain APOBEC enzymes.
- An APOBEC's ability to compete with RPA is a better predictor of genomic damage than mRNA expression or mutation signatures alone.
Related Concept Videos
Restarting Stalled Replication Forks
DNA Damage can Stall the Cell Cycle
Single-Strand DNA Binding Proteins
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
The DNA Replication Fork
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...

